Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providersHematology & Oncology Physician in Scottsdale, AZ
NPI: 1114966298Primary Employer
Mayo Clinic Building - Scottsdale
mayoclinic.org
HQ Phone
Mobile
Get M.D. Cassandra's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardAZ State Medical License
NC State Medical License
UMass Chan Medical School
umassmed.edu
Residency • Internal Medicine
1999 - 2002
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 317 | 451 |
| 2 | 96413Infusion of chemotherapy into a vein up to 1 hour | 264 | 303 |
| 3 | 96375Injection of different drug or substance into a vein for therapy, diagnosis, or prevention | 173 | 418 |
| 4 | 99215Established patient office or other outpatient, visit typically 40 minutes | 152 | 220 |
| 5 | J2405Injection, ondansetron hydrochloride, per 1 mg | 134 | 1,548 |
Authors: Victoria Seewaldt
Journal: J Natl Cancer Inst
Authors: Guru Sonpavde, Irbaz Riaz, Thai Ho, Parminder Singh, Min Kong, Alan Bryce, Haidar Abdul-Muhsin
Journal: Cancers (Basel)
Publication Date: 2023-03-08
Authors: Andrew Armstrong
Journal: Clin Cancer Res
Lead Sponsor: Neurogene Inc.
Collaborators: Merck Sharp & Dohme LLC
Intervention / Treatment: DRUG: NL-201, DRUG: Pembrolizumab Injection [Keytruda]
Lead Sponsor: Elucida Oncology
Intervention / Treatment: DRUG: ELU001
Lead Sponsor: Mayo Clinic
Intervention / Treatment: OTHER: Questionnaire Administration, OTHER: Electronic Health Record Review, OTHER: Best Practice, BEHAVIORAL: Patient Navigation, OTHER: Educational Intervention